Assessing bidirectional associations between cognitive impairment and late age-related macular degeneration in the Age-Related Eye Disease Study 2

被引:13
作者
Le, Jimmy T. [1 ]
Agron, Elvira [2 ]
Keenan, Tiarnan D. L. [2 ]
Clemons, Traci E. [3 ]
Brenowitz, Willa D. [6 ]
Yaffe, Kristine [4 ,5 ]
Chew, Emily Y. [2 ]
机构
[1] Natl Inst Hlth, Natl Eye Inst, Div Extramural Res, Div Epidemiol & Clin Applicat, 6700B RockledgeDrive,Suite 3400, Bethesda, MD 20817 USA
[2] Natl Inst Hlth, Natl Eye Inst, Div Epidemiol & Clin Applicat, Bethesda, MD USA
[3] Emmes Co, LLC, Rockville, MD USA
[4] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA USA
[6] Univ Calif San Francisco, Dept Neurol & Epidemiol & Biostatist, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
age-related macular degeneration; Alzheimer's disease; cognitive impairment; eyes; older adults; ophthalmology; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; GLOBAL PREVALENCE; AREDS; DEMENTIA; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; ANCILLARY; RISK;
D O I
10.1002/alz.12473
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction We aimed to investigate bidirectional associations between cognitive impairment and late age-related macular degeneration (AMD). Methods Participants in the Age-Related Eye Disease Study 2 (AREDS2) received annual eye examinations and cognitive function testing (e.g., Modified Telephone Interview for Cognitive Status [TICS-M]). We examined bidirectional associations between cognitive impairment (e.g., a TICS-M score < 30) and late AMD at 5 and 10 years. Results Five thousand one hundred eighty-nine eyes (3157 participants; mean age 72.7 years) were analyzed and followed for a median of 10.4 years. Eyes of participants with cognitive impairment at baseline were more likely to progress to late AMD at 5 years (hazard ratio [HR], 1.24; 95% confidence interval [CI], 1.08-1.43) and 10 years (HR, 1.20; 95% CI, 1.05-1.37) than eyes of participants without cognitive impairment. Worse baseline AMD severity was not associated with developing cognitive impairment. Discussion Cognitive impairment is associated with late AMD progression in AREDS2. Our finding highlights the importance of eyecare for people with cognitive impairment.
引用
收藏
页码:1296 / 1305
页数:10
相关论文
共 47 条
[41]   Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity AREDS Report 41 [J].
Vitale, Susan ;
Agron, Elvira ;
Clemons, Traci E. ;
Keenan, Tiarnan D. L. ;
Domalpally, Amitha ;
Danis, Ronald P., Jr. ;
Chew, Emily Y. .
JAMA OPHTHALMOLOGY, 2020, 138 (06) :610-617
[42]   REGRESSION-ANALYSIS OF MULTIVARIATE INCOMPLETE FAILURE TIME DATA BY MODELING MARGINAL DISTRIBUTIONS [J].
WEI, LJ ;
LIN, DY ;
WEISSFELD, L .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1989, 84 (408) :1065-1073
[43]  
Wong TY, 2002, AM J OPHTHALMOL, V134, P828
[44]   Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis [J].
Wong, Wan Ling ;
Su, Xinyi ;
Li, Xiang ;
Cheung, Chui Ming G. ;
Klein, Ronald ;
Cheng, Ching-Yu ;
Wong, Tien Yin .
LANCET GLOBAL HEALTH, 2014, 2 (02) :E106-E116
[45]   Genome-wide analysis of disease progression in age-related macular degeneration [J].
Yan, Qi ;
Ding, Ying ;
Liu, Yi ;
Sun, Tao ;
Fritsche, Lars G. ;
Clemons, Traci ;
Ratnapriya, Rinki ;
Klein, Michael L. ;
Cook, Richard J. ;
Liu, Yu ;
Fan, Ruzong ;
Wei, Lai ;
Abecasis, Goncalo R. ;
Swaroop, Anand ;
Chew, Emily Y. ;
Weeks, Daniel E. ;
Chen, Wei .
HUMAN MOLECULAR GENETICS, 2018, 27 (05) :929-940
[46]   Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer's disease [J].
Yang, SP ;
Bae, DG ;
Kang, HJ ;
Gwag, BJ ;
Gho, YS ;
Chae, CB .
NEUROBIOLOGY OF AGING, 2004, 25 (03) :283-290
[47]   Lower cognitive function in patients with age-related macular degeneration: a meta-analysis [J].
Zhou, Li-Xiao ;
Sun, Cheng-Lin ;
Wei, Li-Juan ;
Gu, Zhi-Min ;
Lv, Liang ;
Dang, Yalong .
CLINICAL INTERVENTIONS IN AGING, 2016, 11 :215-223